Status:
COMPLETED
Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage
Lead Sponsor:
Gynuity Health Projects
Collaborating Sponsors:
El Galaa Teaching Hospital
University of Alexandria
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via intravenous (IV) infusion or IV bolus reduces the rate of postpartum hemorrhage compared to intramusc...
Detailed Description
The study will compare the effect of IV infusion or IV bolus to IM oxytocin administration with respect to mean blood loss and the proportion of women who experience blood loss greater than or equal t...
Eligibility Criteria
Inclusion
- All women who present in active labor for a live birth at the study hospital will be considered for participation in the study
Exclusion
- Planned or transferred for delivery via Cesarean section
- Administration of a pre-delivery uterotonic to induce or augment labor
- Unable to provide informed consent due to mental impairment, distress during labor or other reason
Key Trial Info
Start Date :
April 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
4983 Patients enrolled
Trial Details
Trial ID
NCT01914419
Start Date
April 1 2014
End Date
September 1 2015
Last Update
March 11 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Shatby Maternity Hospital, Alexandria University
Alexandria, Egypt
2
El Galaa Teaching Hospital
Cairo, Egypt